Trade-Ideas LLC identified

Eastman Chemical

(

EMN

) as a post-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Eastman Chemical as such a stock due to the following factors:

  • EMN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $78.3 million.
  • EMN is down 6.7% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in EMN with the Ticky from Trade-Ideas. See the FREE profile for EMN NOW at Trade-Ideas

More details on EMN:

Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The stock currently has a dividend yield of 2.6%. EMN has a PE ratio of 11. Currently there are 7 analysts that rate Eastman Chemical a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Eastman Chemical has been 1.3 million shares per day over the past 30 days. Eastman Chemical has a market cap of $10.3 billion and is part of the basic materials sector and chemicals industry. The stock has a beta of 1.54 and a short float of 3.5% with 3.76 days to cover. Shares are up 4.2% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Eastman Chemical as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

Highlights from the ratings report include:

  • EASTMAN CHEMICAL CO has improved earnings per share by 48.2% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. During the past fiscal year, EASTMAN CHEMICAL CO increased its bottom line by earning $5.66 versus $4.94 in the prior year. This year, the market expects an improvement in earnings ($6.97 versus $5.66).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Chemicals industry. The net income increased by 46.8% when compared to the same quarter one year prior, rising from $171.00 million to $251.00 million.
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. In comparison to other companies in the Chemicals industry and the overall market on the basis of return on equity, EASTMAN CHEMICAL CO has underperformed in comparison with the industry average, but has greatly exceeded that of the S&P 500.
  • EMN, with its decline in revenue, slightly underperformed the industry average of 5.7%. Since the same quarter one year prior, revenues slightly dropped by 8.5%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.